Heart valve follow-up study for bicuspid aorta patients
Part of Genetic & congenital, Heart & circulation clinical trials.
This study follows patients who have a bicuspid aortic valve—a heart valve with two leaflets instead of three. Researchers track how this condition changes over time to better understand its long-term effects and help guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had an echocardiogram (heart ultrasound) that showed a bicuspid aortic valve
- You have not had surgery on your bicuspid valve before entering the study
- You have not had surgery on your ascending aorta (the main artery leaving your heart) before entering the study
- You are willing to participate and allow follow-up care
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients with aortic stenosis (a narrowing of the heart valve that controls blood flow from the heart) to understand how the condition progresses over time and what outcomes patients experience. By reviewing medical records and contacting patients for follow-up, researchers hope to better predict who is at higher risk and inform treatment decisions.
This study looks at how genes may affect the risk of calcium buildup in the aortic valve in people with a bicuspid aortic valve. By joining, you help researchers find better ways to predict and manage this heart condition.
This study is a registry that collects health information from adults with bicuspid aortic valve disease. It may help doctors better understand outcomes and guide future care for patients and families affected by this condition.
This study looks at people with a bicuspid aortic valve (a valve with two flaps instead of three) in Chinese patients. It collects information about this condition to better understand it.
This study looks for genetic (inherited) differences that may be linked to bicuspid aortic valve (BAV). It includes people with BAV and close family members to help understand why BAV happens and whether genes play a role.
This trial looks at how the ascending aorta (the main artery near the heart) changes over time after transcatheter aortic valve replacement. It may help doctors predict who is at risk of aorta enlargement after this less-invasive valve procedure.
Hear when a new Aortic Valve, Bicuspid trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.